[
  {
    "ts": null,
    "headline": "GSK: Depemokimab And Jemperli Lead Next Wave (Rating Upgrade)",
    "summary": "Discover why GSK is upgraded to 'Strong Buy' with strong earnings, new drug approvals, and low P/E valuation.",
    "url": "https://finnhub.io/api/news?id=47d4986b94f4f823645b03528c249884f1a5e3488d42f6f9b6b96af8685a05fe",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765557767,
      "headline": "GSK: Depemokimab And Jemperli Lead Next Wave (Rating Upgrade)",
      "id": 137771795,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/939034648/image_939034648.jpg?io=getty-c-w1536",
      "related": "REGN",
      "source": "SeekingAlpha",
      "summary": "Discover why GSK is upgraded to 'Strong Buy' with strong earnings, new drug approvals, and low P/E valuation.",
      "url": "https://finnhub.io/api/news?id=47d4986b94f4f823645b03528c249884f1a5e3488d42f6f9b6b96af8685a05fe"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron (REGN) Just Flashed Golden Cross Signal: Do You Buy?",
    "summary": "Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?",
    "url": "https://finnhub.io/api/news?id=e8a03c1019b4875df865ac98d969df6ba46f0358895bc44798a39d595fa742f1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765550101,
      "headline": "Regeneron (REGN) Just Flashed Golden Cross Signal: Do You Buy?",
      "id": 137769603,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?",
      "url": "https://finnhub.io/api/news?id=e8a03c1019b4875df865ac98d969df6ba46f0358895bc44798a39d595fa742f1"
    }
  }
]